CannaPharmaRx, Inc. Announces New Financial Controller to Be Based in NJ Headquarters

Warning message

The subscription service is currently unavailable. Please try again later.

CARNEY’S POINT, NJ–(Marketwired – December 05, 2014) – CannaPharmaRx, Inc., (OTCQB: GDHC), the New Jersey-based pharmaceutical research and discovery company, today announced the hiring of Thomas J. Della-Franco III as Financial Controller. Mr. Della-Franco will work on a consulting basis out of the company’s new headquarters in Carney’s Point, New Jersey.

“Tom’s diverse work experience is an excellent fit for our rapidly evolving company. He is a highly accomplished financial executive with expertise in manufacturing, importing and distribution, and with demonstrated success in financing, refinancing, restructurings and mergers & acquisitions,” said Gerry Crocker, CEO, CannaPharmaRx.

In his most recent position as Chief Financial Officer for ZPC Holdings, Mr. Della-Franco led the company’s Sarbanes Oxley (SOX) compliance, strategic acquisitions, LBOs, private equity rounds and was the key contact for due diligence rounds prior to the company’s sale to a Fortune 500 company. Prior to ZPC Holdings, Mr. Della-Franco worked as Senior Auditor for...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.